Silo pharma comments on recent promotional and trading activities at request of otc markets

New jersey , dec. 04, 2020 (globe newswire) -- silo pharma, inc. (otcqb: silo) a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, today announced that it has been requested by the otc markets group (“the otc markets”) to comment on recent promotional activity.

SILO Ratings Summary

SILO Quant Ranking